azacitidine,venetoclax
roche,abbvie
['viale-a', 'venetoclax']
long term follow up of patient who underwent hsct after venetoclax and hma on phase 1b(31) and viale-a(2) studies. os 29.9 m #eha2023 
Director of Leukemia, Hospital of University of Pennsylvania, Philadelphia. #Pennmedicine Alumni Mayo Clinic Rochester (IM’05), Johns Hopkins Hospital (Med Onc)